Active Ingredient
Guaifenesin 600 mg (for 600 mg)
Guaifenesin 1200 mg (for 1200 mg)
The following Structured Product Label (SPL) was submitted to the FDA by Innovus Pharmaceuticals, Inc. for the product Crcle Guaifenesin Extended-release Tablets, 600 Mg (NDC 57483-270). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 600 mg (for 600 mg)
Guaifenesin 1200 mg (for 1200 mg)
Expectorant
cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)
Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing.
store between 20-25°C (68-77°F)
carbomer homopolymer type B; hypromellose, Lake of FD&C Blue 1, magnesium stearate, microcrystalline cellulose; sodium starch glycolate
Contact 1-877-770-3183 Mon-Fri 8:00 AM EST to 5:00 PM PST.
* Please review the disclaimer below.